I
Inovio Pharmaceuticals, Inc. (INO)
NCM – Real vaqt narxi. Valyuta: USD
0.84
+0.04 (5.48%)
Yopilishda: Oct 22, 2026, 4:00 PM EDT
0.85
+0.01 (1.32%)
Bozordan keyin: Oct 22, 2026, 7:40 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
0.84
+0.04 (5.48%)
Yopilishda: Oct 22, 2026, 4:00 PM EDT
0.85
+0.01 (1.32%)
Bozordan keyin: Oct 22, 2026, 7:40 PM EDT
No Data
Ushbu aksiya uchun yangiliklar yo'q.
Kompaniyaning naqd pul zahiralari $31.5M umumiy qarzdan $8.0M sezilarli darajada ko'p bo'lib, kuchli moliyaviy moslashuvchanlikni ta'minlaydi
Jami joriy aktivlar $39.9M jami joriy majburiyatlarni $39.9M zo'rg'a qoplaydi, bu cheklangan likvidlikni ko'rsatadi
Qarz/kapital nisbati (1.8) tarmoq o'rtachasidan ancha yuqori bo'lib, haddan tashqari leverajni aks ettiradi
Foiz xarajatlari mavjud, ammo EBIT ma'lumotlari mavjud emas, bu potentsial rentabellik muammolarini ko'rsatadi
Salbiy erkin pul oqimi -$18.0M kompaniyaning qayta investitsiya qilish yoki qarzni to'lash qobiliyatini cheklaydi
| KO‘RSATKICH NOMI | KO‘RSATKICH | SANOAT O‘RTACHASI | 5 YILLIK TREND | BALL |
|---|---|---|---|---|
| Joriy likvidlik ko'rsatkichi | 1.00 | 4.66 | 6.0 | |
| Tezkor likvidlik nisbati | 1.00 | 4.27 | 6.0 | |
| Qarz/Kapital nisbati | 1.83 | 0.15 | 3.0 | |
| Qarz/Aktivlar nisbati | 0.16 | 0.11 | 8.0 | |
| Foiz to‘lov qoplami | N/A | -3.18 | 1.0 | |
| O‘rtacha ball | 4.8 | |||
| KO‘RSATKICH | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Jami daromad | 10M | 832K | 218K | 65K | N/A |
| Yalpi foyda | 5M | -3M | -3M | -3M | -3M |
| Operatsion daromad | -274M | -135M | -114M | -87M | -79M |
| Sof foyda | -280M | -135M | -107M | -85M | -67M |
| EBITDA | -269M | -132M | -111M | -84M | -76M |
| NOMI | KOEFF. | SANOAT | 5 YIL | BALL |
|---|---|---|---|---|
| Yalpi marja % | N/A | 83.18 | 1.0 | |
| Operatsion marja % | N/A | -29.82 | 1.0 | |
| Sof marja % | N/A | -41.34 | 1.0 | |
| EBITDA marja % | N/A | -26.03 | 1.0 | |
| Pul oqimi marja % | N/A | -43.91 | 1.0 | |
| O‘rtacha ball | 1.0 | |||
| NOMI | KOEFF. | SANOAT | 5 YIL | BALL |
|---|---|---|---|---|
| ROA | -112.56 | -20.69 | 1.0 | |
| ROE | -304.53 | -17.54 | 1.0 | |
| ROIC | -236.59 | -18.98 | 1.0 | |
| ROCE | -599.27 | -25.49 | 1.0 | |
| O‘rtacha ball | 1.0 | |||
| Nomi | DAROMAD O'SISHI | EPS O‘SISHI | BALL |
|---|---|---|---|
| Joriy chorak | N/A | 77.39 | 5.5 |
| Keyingi chorak | N/A | -405.56 | 1.0 |
| Joriy yil | 920.26 | 57.83 | 10 |
| Keyingi yil | 7490 | 44.1 | 10 |
| O‘rtacha ball | 6.6 | ||
| NOMI | DAROMAD | SOF FOYDA | EPS | FCF | BALL |
|---|---|---|---|---|---|
| Chorak/Chorak | 999 | 69.45 | 75 | 16.41 | 9.8 |
| Yil/Yil | 999 | 74.44 | 88.52 | 13.41 | 9.5 |
| 3 yil o‘rtacha | -78.55 | 31.04 | 48.65 | 24.57 | 7.8 |
| 5 yil o‘rtacha | 33.3 | 3.7 | 25.95 | 10.55 | 7.8 |
| O‘rtacha ball | 8.7 | ||||
| NOMI | KOEFF. | SANOAT | 5 CHORAK | BALL |
|---|---|---|---|---|
| P/E | N/A | 20.20 | 1.0 | |
| PEG (5 yillik kutilayotgan) | N/A | 1.20 | 1.0 | |
| P/S | N/A | 10.07 | 1.0 | |
| P/B | 14.98 | 4.38 | 2.8 | |
| O‘rtacha ball | 1.5 | |||
Insufficient positive free cash flow for DCF analysis
| NOMI | JORIY | SANOAT | BALL |
|---|---|---|---|
| Dividend foizi | N/A | 1.20 | N/A |
| To'lov koeffitsienti | N/A | 27.45 | N/A |
| 5 yillik dividend o‘sishi | N/A | 4.94 | N/A |
| Dividend oshgan yillar | 0.00 | 0.00 | 1.0 |
| O‘rtacha ball | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NOMI | MASSHTAB | BALL |
|---|---|---|
| Bozor ulushi | N/A | N/A |
| Nomoddiy aktivlar | N/A | N/A |
| O'zgartirish xarajatlari | N/A | N/A |
| Tarmoq ta'siri | N/A | N/A |
| Masshtab ta'siri | N/A | N/A |
| O‘rtacha ball | 1.0 | |